ECSP972256A - NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES - Google Patents
NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASESInfo
- Publication number
- ECSP972256A ECSP972256A ECSP972256A ECSP972256A EC SP972256 A ECSP972256 A EC SP972256A EC SP972256 A ECSP972256 A EC SP972256A EC SP972256 A ECSP972256 A EC SP972256A
- Authority
- EC
- Ecuador
- Prior art keywords
- prophylaxis
- degenerative diseases
- pain
- diseases
- new treatment
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Derivados y análogos de benzopirano se describen como útiles para el tratamiento y/o la profilaxis de enfermedades degenerativas tales como corea de huntingdon, esquizofrenia, déficits neurológicos asociados con el SIDA, trastornos del sueño(incluidos trastornos del ritmo circadiano, insomnio y narcolepsia), tios por (ejemplo, síndrome de Giles de la Tourette), lesión traumática del cerebro, zumbido, neuralgia, especialmente neuralgia trigémina, dolor neuropático, dolor dental, dolor de cáncer, actividad neuronal inapropiada que resulta en una neurodistesia en enfermedades tales como diabetes, EM y la enfermedad de la neurona motora, ataxias, rigidez muscular (espasmos) y disfunción de la unión temporomandibular.Benzopyran derivatives and analogs are described as useful for the treatment and / or prophylaxis of degenerative diseases such as huntingdon's chorea, schizophrenia, neurological deficits associated with AIDS, sleep disorders (including circadian rhythm disorders, insomnia and narcolepsy), uncles for example (Giles de la Tourette syndrome), traumatic brain injury, tinnitus, neuralgia, especially trigeminal neuralgia, neuropathic pain, dental pain, cancer pain, inappropriate neuronal activity resulting in neurodystesia in diseases such as diabetes, MS and motor neuron disease, ataxias, muscle stiffness (spasms) and dysfunction of the temporomandibular junction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP972256 ECSP972256A (en) | 1997-09-15 | 1997-09-15 | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP972256 ECSP972256A (en) | 1997-09-15 | 1997-09-15 | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP972256A true ECSP972256A (en) | 1998-11-30 |
Family
ID=42043087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP972256 ECSP972256A (en) | 1997-09-15 | 1997-09-15 | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP972256A (en) |
-
1997
- 1997-09-15 EC ECSP972256 patent/ECSP972256A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2082887T3 (en) | FLUPIRTINE IN COMBINATION WITH ANTIPARKINSONIANS TO COMBAT MUSCULAR SPASMS. | |
DK1303495T3 (en) | Substituted 5-alkylnylpyrimidines with neurotrophic activity | |
IL225192A (en) | Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury | |
DE60324449D1 (en) | INHIBITORS OF PHOSPHODIESTERASE OF CYCLIC N, AND THEIR USE IN THERAPY | |
ATE381935T1 (en) | USE OF TRIACETYLURIDINE TO TREAT MITOCHONDRIAL DISEASES | |
DE69827513D1 (en) | ARRANGEMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS BY INFUSION OF NERVOUS GROWTH FACTORS IN THE BRAIN | |
EP0970720A3 (en) | Treatment of pain and the nervous system | |
ATE209492T1 (en) | USE OF 1,2,4-TRIAZOLO(1,5-C)PYRIMIDINE HETEROCYCLIC ANALOGUE FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS | |
FI964341A0 (en) | Process and equipment for the reduction of adipose tissue in certain parts of the body by combined heat treatment and muscle function | |
ATE229806T1 (en) | ACTIVE SUBSTANCE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
CR6620A (en) | AMINO BICYCLE ACIDS AS PHARMACEUTICAL AGENTS | |
GT200000203A (en) | COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS. | |
PL344304A1 (en) | Combination therapy for treatment of bipolar disorders | |
AR008838A1 (en) | NEW TREATMENT. | |
BR0009296A (en) | Pharmaceutical composition, processes to induce differentiation of neural cells from target cells, to promote neural activity in an individual, and to prevent or treat disorders and diseases that can be prevented by promoting neural cell differentiation and / or neural activity, and, use a compound | |
ECSP972256A (en) | NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES | |
ID23528A (en) | THERAPEUTIC TREATMENT FOR SKIN DISORDERS | |
MXPA00010254A (en) | The treatment of sexual dysfunction in certain patient groups. | |
IL164779A0 (en) | Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other oculat disorders | |
ATE512664T1 (en) | COMPOSITION CONTAINING SPHINGOMYELIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS | |
AU2003227593A1 (en) | New analogs of nitrobenzylthioinosine | |
HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
Daniel | ECT seizure duration and alleviation of depression | |
MY116362A (en) | Use of selegiline for the treatment of epileptic disorders | |
ES1034986Y (en) | APPARATUS FOR THE TREATMENT OF THE HUMAN BODY. |